Glenmark Pharmaceuticals Rights Issue
Glenmark Pharmaceuticals has not split the face value of the share since 29 Aug, 2023
Last updated on 30 Aug, 2026 | 07:20 IST
Glenmark Pharmaceuticals Rights Issue Details
Rights Ratio | Face Value  | Premium | Ex-Right Date | Record Date  | Announcement Date |
|---|---|---|---|---|---|
| No data found | |||||
*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.
FAQs
Who is eligible to apply for Glenmark Pharma rights issue?
Existing shareholders of Glenmark Pharma as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.
How can existing shareholders apply for Glenmark Pharma rights issue?
Shareholders can apply for Glenmark Pharma rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.
Is the rights issue of Glenmark Pharma mandatory for existing shareholders?
No! Participation in Glenmark Pharma rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.
Has Glenmark Pharma announced any rights issues in the past?
No, Glenmark Pharma hasn’t had any right issues as of {{current_date}} in last 2023-2025
What was the last rights issue price and ratio for Glenmark Pharma?
No, Glenmark Pharma hasn’t had any right issues as of {{current_date}} in last 2023-2025